| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
1 Chief of Oral & Maxillofacial Surgery at Veterans Administration Medical Center in East Orange, New Jersey; Professor of Surgery at the University of Medicine and Dentistry of New Jersey, New Jersey Medical School, in Newark, New Jersey; and Clinical Professor of Oral & Maxillofacial Surgery at Fairleigh S. Dickinson Jr. College of Dental Medicine in Hackensack, New Jersey.
1. Drinkers and cigarette smokers are at very high risk for the development of upper aerodigestive tract and lung squamous carcinomas. 2. The floor of the mouth, the ventrolateral tongue, and the soft palate are high-risk sites within the oral cavity and oropharynx. 3. Mucosal erythroplasia rather than leukoplakia is the earliest visual sign of oral and pharyngeal carcinomas. 4. Areas of mucosal abnormality, especially redness or inflammation in high-risk sites, that persist for more than 14 days without obvious etiology or resolution should be biopsied. 5. Asymptomatic, erythroplastic lesions should not be regarded merely as precancerous changes. The evidence indicates that these lesions in high-risk sites should be considered to be invasive carcinoma or at the very least carcinoma in situ, unless proven otherwise by biopsy. 6. Toluidine blue staining is a useful diagnostic adjunct, particularly as a method of ruling out false-negative clinical impressions. It may also be used as a screening rinse in high-risk patients to encompass the entire oral mucosa after a negative clinical examination and as a guide to improve biopsy yields. 7. If oral or pharyngeal cancer is identified, evaluations of the larynx, hypopharynx, esophagus, and lungs should be performed to rule out second primary cancers. Yearly aerodigestive surveillance should be continued after satisfactory treatment of the index cancer.
Early Detection, Diagnosis, and Management of Oral and Oropharyngeal Cancer
Arthur Mashberg DDS1 and
Alan M. Samit DDS2
2 Assistant Chief of Oral & Maxillofacial Surgery at Veterans Administration Medical Center in East Orange, New Jersey.
This article has been cited by other articles:
|
|
 |
|
  Z. S. Peacock, M. A. Pogrel, and B. L. Schmidt Exploring the Reasons for Delay in Treatment of Oral Cancer J Am Dent Assoc, October 1, 2008; 139(10): 1346 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Rosin, W. L. Lam, C. Poh, N. D. Le, R. J. Li, T. Zeng, R. Priddy, and L. Zhang 3p14 and 9p21 Loss Is a Simple Tool for Predicting Second Oral Malignancy at Previously Treated Oral Cancer Sites Cancer Res., November 15, 2002; 62(22): 6447 - 6450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Guo, K. Yamaguchi, M. Sanchez-Cespedes, W. H. Westra, W. M. Koch, and D. Sidransky Allelic Losses in OraTest-directed Biopsies of Patients with Prior Upper Aerodigestive Tract Malignancy Clin. Cancer Res., July 1, 2001; 7(7): 1963 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.L. Crowe, G.E. Milo, and C.E. Shuler Keratin 19 Downregulation by Oral Squamous Cell Carcinoma Lines Increases Invasive Potential Journal of Dental Research, June 1, 1999; 78(6): 1256 - 1263. [Abstract] [PDF]
|
|
|
|
 |
|
 J. G. Spangler Open Your Mouth and Say, 'Ahhh: Oral Cancer Screening and Family Physicians Arch Fam Med, July 1, 1995; 4(7): 585 - 586. [Abstract] [PDF]
|
|
|
|
|
|
H. S. Goodman, J. A. Yellowitz, and A. M. Horowitz Oral Cancer Prevention: The Role of Family Practitioners Arch Fam Med, July 1, 1995; 4(7): 628 - 636. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
